Kallikrein 13 antibody
Quick Overview for Kallikrein 13 antibody (ABIN7229308)
Target
See all Kallikrein 13 (KLK13) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- KLK13 Polyclonal Antibody
-
Specificity
- The antibody detects endogenous levels of KLK13 protein
-
Purification
- The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen
-
Immunogen
- Synthesized peptide derived from part region of human KLK13 protein
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:5000-1:20000).
-
Comment
-
Primary Antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium Azide as preservative and 50 % Glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))
-
Alternative Name
- KLK13
-
Background
- Rabbit Anti-KLK13 Polyclonal Antibody,Kallikrein-13, Kallikrein-like protein 4, KLK-L4,Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK13 is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer.,KLK13
-
Molecular Weight
- observerd band 30kDa
-
Gene ID
- 26085
-
UniProt
- Q9UKR3
-
Pathways
- Complement System
Target
-